[Neuromuscular blockade monitoring. Part 2].
Ortiz-Gómez
J R
JR
Servicio de Anestesiología y Reanimación, Hospital Virgen del Camino, Pamplona, Navarra. jortizgo@cfnavarra.es
Fabregat-López
J
J
Palacio-Abizanda
F J
FJ
Fornet-Ruiz
I
I
Pérez-Cajaraville
J
J
Ariño-Irujo
J J
JJ
Calbet-Mañueco
A
A
De la Calle-Elguezabal
P A
PA
Velasco-Barrio
J M
JM
López-Timoneda
F
F
D004558:Electric Stimulation / Q000379:methods; D004568:Electrodiagnosis / Q000295:instrumentation / Q000379:methods; D004867:Equipment Design; D019317:Evidence-Based Medicine; D006801:Humans; D007431:Intraoperative Complications / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D016343:Monitoring, Intraoperative / Q000295:instrumentation / Q000379:methods; D018482:Muscle, Skeletal / Q000294:innervation / Q000502:physiology; D019148:Neuromuscular Blockade / Q000009:adverse effects; D009466:Neuromuscular Blocking Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D010525:Peripheral Nerves / Q000502:physiology; D017410:Practice Guidelines as Topic
D009466:Neuromuscular Blocking Agents